A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary glomerular disease or nephrosclerosis (CASSIOPEIR trial), rationale and study…

Overview of attention for article published in BMC Nephrology, September 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

So far, Altmetric has seen 1 public wall post.

A multinational phase IIb/III trial of beraprost sodium, an orally active prostacyclin analogue, in patients with primary…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.